American Association for Cancer Research Inc

EIN: 236251648 501(c)(3) Medical Research

Philadelphia, PA

Total Revenue
$137,428,364
Total Expenses
$88,032,459
Total Assets
$291,810,436
Net Assets
$220,194,890
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1907
Legal Domicile
NY
Principal Officer
MICHAEL STEWART
Phone
2154409300
Tax Period
2024-01-01 to 2024-12-31

American Association for Cancer Research Inc, founded in 1907, is a major nonprofit in the Medical Research sector that reported $137.4M in total revenue in fiscal year 2024. Revenue surged 85% from the prior year, signaling strong growth momentum. The organization ran a surplus of $49.4M, a strong 36% operating margin.

Mission

THE MISSION OF THE AACR IS TO PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION, AND COLLABORATION. THROUGH ITS PROGRAMS AND SERVICES, THE AACR FOSTERS RESEARCH IN CANCER AND RELATED BIOMEDICAL SCIENCE; ACCELERATES THE DISSEMINATION OF NEW RESEARCH FINDINGS AMONG SCIENTISTS AND OTHERS DEDICATED TO THE CONQUEST OF CANCER; PROMOTES SCIENCE EDUCATION AND TRAINING; AND ADVANCES THE UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT THROUGHOUT THE WORLD.

Program Service Accomplishments

Program 1
Expenses: $14,700,817

RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS AND CAREER DEVELOPMENT AWARDS.

Program 2
Expenses: $24,519,657 Revenue: $33,662,478

ANNUAL MEETING AND SPECIAL CONFERENCES ATTENDED BY MEMBERS AND NON-MEMBERS FOR THE PRESENTATION OF SCIENTIFIC RESEARCH. ALSO INCLUDES EDUCATIONAL WORKSHOPS FOR TRAINING YOUNG INVESTIGATORS.

Program 3
Expenses: $13,312,612 Revenue: $18,781,283

PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER...

Read more

PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER THERAPEUTICS", "CANCER PREVENTION RESEARCH", "CANCER DISCOVERY", "CANCER IMMUNOLOGY RESEARCH", "BLOOD CANCER DISCOVERY", AND "CANCER RESEARCH COMMUNICATIONS".

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $48,246,384
Program Service Revenue $67,669,562
Investment Income $20,614,173
Other Revenue $898,245
TOTAL REVENUE $137,428,364

Expense Breakdown

Grants Paid $11,210,125
Salaries & Benefits $32,905,715
Fundraising Expenses $1,204,000
Program Expenses $76,379,553
Other Expenses $43,916,619
TOTAL EXPENSES $88,032,459

Year-over-Year Comparison

2024 2023 Change
Revenue $137,428,364 $74,316,369 +0.8%
Expenses $88,032,459 $80,202,057 +0.1%
Net Income $49,395,905 $-5,885,688 -9.4%
Key Indicators
✗ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
24
Independent Members
24
Employees
301
Volunteers
5500

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✓ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
9
$2,592,600
Total Directors
27
$0
Key Employees
2
$832,379
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 35.0
Officer
$1,809,255 $64,914 $2,075,197
MICHAEL STEWART SR. VICE PRESIDENT, CFO 35.0
Officer
$430,500 $64,403 $517,403
JON G RETZLAFF VP. Science Policy & Gov. Affa 40.0
Key Emp
$403,520 $55,903 $459,423
YIXIAN ZHANG VP, RESEARCH AND GRANTS 40.0
Key Emp
$312,000 $60,956 $372,956
PAUL J DRISCOLL CHIEF MARKETING OFFICER AND VP 40.0
Highest
$308,700 $58,972 $367,672
CHRISTINE B BATTLE VP. SCIENTIFIC PUBLICATIONS 40.0
Highest
$326,000 $39,841 $365,841
RICHARD G BUCK CHIEF COMMUNICATIONS OFFICER 40.0
Highest
$304,350 $52,883 $357,233
JOSEPH S PONTOSKI VP. FINANCE AND BUSINESS ADMIN 40.0
Highest
$300,000 $50,363 $350,363
MARY BALLINGER VP, MEETINGS AND EXHIBITS 40.0
Highest
$270,750 $50,195 $320,945
DR PHILIP GREENBERG PRESIDENT (JAN-MAR) 5.0
Officer Director
$0 $0 $0
DR PATRICIA LORUSSO PRESIDENT (APR-DEC) 5.0
Officer Director
$0 $0 $0
DR PATRICIA LORUSSO PRESIDENT-ELECT (JAN-MAR) 5.0
Officer Director
$0 $0 $0
DR LILLIAN SUI PRESIDENT-ELECT (APR-DEC) 5.0
Officer Director
$0 $0 $0
DR LISA COUSSENS PAST PRESIDENT (JAN-MAR) 5.0
Officer Director
$0 $0 $0
DR PHILIP GREENBERG PAST PRESIDENT (APR-DEC) 5.0
Officer Director
$0 $0 $0
DR WILLIAM N HAIT TREASURER 5.0
Officer Director
$0 $0 $0
Dr JOHN CARETHERS DIRECTOR 2.0
Director
$0 $0 $0
DR CHRISTINE LOVLY DIRECTOR 2.0
Director
$0 $0 $0
DR ELIZABETH PLATZ DIRECTOR 2.0
Director
$0 $0 $0
DR ALICE SHAW DIRECTOR 2.0
Director
$0 $0 $0
DR JEDD WOLCHOK DIRECTOR 2.0
Director
$0 $0 $0
DR CHRISTINA CURTIS DIRECTOR 2.0
Director
$0 $0 $0
DR WILLIAM PAO DIRECTOR 2.0
Director
$0 $0 $0
DR KIMBERLY STEGMAIER DIRECTOR 2.0
Director
$0 $0 $0
DR ROBERT VONDERHEIDE DIRECTOR 2.0
Director
$0 $0 $0
DR JOHN CARPTEN DIRECTOR 2.0
Director
$0 $0 $0
DR MANUEL HIDALGO DIRECTOR 2.0
Director
$0 $0 $0
DR ELECTRA PASKETT DIRECTOR 2.0
Director
$0 $0 $0
DR KATERINA POLITI DIRECTOR 2.0
Director
$0 $0 $0
DR JEAN-CHARLES SORIA DIRECTOR 2.0
Director
$0 $0 $0
DR CATHERINE WU DIRECTOR 2.0
Director
$0 $0 $0
DR NINA BHARDWAJ DIRECTOR 2.0
Director
$0 $0 $0
DR LUIS DIAZ DIRECTOR 2.0
Director
$0 $0 $0
DR SUSAN GALBRAITH DIRECTOR 2.0
Director
$0 $0 $0
DR THOMAS LYNCH DIRECTOR 2.0
Director
$0 $0 $0
DR LISA NEWMAN DIRECTOR 2.0
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $137,428,364 $88,032,459 $291,810,436 $49,395,905
2023 $74,316,369 $80,202,057 $241,949,585 $-5,885,688
2022 $83,093,510 $83,018,160 $231,693,702 $75,350
2021 $103,171,549 $68,261,079 $261,131,206 $34,910,470
2020 $110,036,275 $95,785,864 $225,756,253 $14,250,411
2019 $124,747,357 $119,310,729 $183,918,208 $5,436,628
2018 $115,485,438 $108,581,578 $156,846,789 $6,903,860
Explore More Nonprofits
→Top 100 Nonprofits in Pennsylvania →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare American Association for Cancer Research Inc with other nonprofits in Pennsylvania and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.